Wegovy 0.5mg: the facts behind the second dose

The myth: 0.5mg is just a weak version of the real treatment

A common assumption is that the early doses of Wegovy are token gestures, that the medicine only starts working once you hit a higher number. That's not quite right. Semaglutide begins acting on GLP-1 receptors from the very first injection. At 0.25mg and then 0.5mg, where the body is genuinely exposed to the drug at a meaningful level, what's being managed is the pace of that exposure, not whether it happens at all.

The reason dose titration exists is physiological. GLP-1 receptor agonists slow gastric emptying and influence signals in the brain that govern hunger and fullness. Ramping up quickly would mean far more nausea, vomiting and digestive disruption than most people could tolerate. The graduated schedule (described in the semaglutide overview) is designed so that by the time you reach the maintenance doses, your system has already acclimatised to how the medicine works.

So 0.5mg is not a placebo warm-up. It's the first step at which many people begin to notice a mild reduction in appetite, though the scale of that effect varies considerably between individuals. Clinical trials that produced Wegovy's headline results ran all participants through this exact early stage, the 0.5mg week is part of the evidence base, not separate from it. According to the NHS semaglutide medicines page, the full titration ladder runs from 0.25mg to the 2.4mg maintenance dose, with each step lasting approximately four weeks.

What actually happens at 0.5mg, week by week

After four weeks at 0.25mg, your prescriber's schedule moves you to 0.5mg. For most people this step brings a modest but real increase in the medicine's effects. Appetite suppression tends to become slightly more noticeable. Some people also find that the gastrointestinal effects (nausea, loose stools, burping, a heavy or full feeling after small amounts of food) are more pronounced at 0.5mg than they were at 0.25mg, simply because the dose has increased.

That is normal and expected. The side-effect profile of semaglutide is well characterised: GI symptoms are the most common, generally mild to moderate, and tend to ease within a few days to a couple of weeks as the body adjusts. If you find the jump to 0.5mg particularly hard-going, the right conversation is with your prescriber, not a decision to skip or delay doses unilaterally, which can disrupt the process.

Week five on Wegovy can feel like a reset of sorts. If you want more context on what that transition looks like, the week five guide covers the practical picture in more detail. The key habit at this stage is consistency: same day each week, same general routine around injection time. One of the things our clinical team hears regularly is that people feel tempted to inject early when they've had a harder week hunger-wise, the schedule exists for a reason, and holding to it matters.

Where 0.5mg sits in the full Wegovy schedule

The licensed titration ladder for Wegovy injection runs: 0.25mg, 0.5mg, 1.0mg, 1.7mg, 2.4mg. Each step lasts around four weeks, meaning you reach 0.5mg in week five and stay there until around week nine, when the move to 1.0mg would typically occur. The Wegovy 1mg stage is where many people report the appetite effects becoming more substantial.

The MHRA has also approved a higher 7.2mg maintenance dose (and, from April 2026, a dedicated single-dose 7.2mg pen) though that sits well beyond the early titration phase most readers searching this topic are currently navigating. For now, 0.5mg is exactly where the licensed schedule expects you to be at this point.

The full dose journey, including the evidence on what the higher doses produce in clinical trials, is covered on the Wegovy treatment page. NICE's appraisal of semaglutide for weight management (NICE TA875) sets out the clinical framework in which this treatment is recommended in the UK. Understanding the full picture (not just the dose you're currently on) is genuinely useful.

Cost, access, and what the 0.5mg pen actually involves

Wegovy is a prescription-only medicine. You cannot buy any dose of it, including 0.5mg, without a valid prescription following a clinical assessment. The prescription-only status exists because the risks and benefits need to be weighed by a qualified prescriber who knows your medical history, not because the process needs to be complicated.

For context on what private treatment costs in the UK at different dose stages, the weight loss treatments overview explains the pricing structure and what a legitimate private service includes. One thing worth being clear about: the 0.5mg pen is not priced or available differently from other Wegovy doses in any meaningful consumer sense, each pen contains four weekly doses at whichever strength you're prescribed, and legitimate supply comes only through a registered pharmacy following a proper clinical assessment. Any seller offering Wegovy at any dose level without going through that process is operating outside UK law.

If you're currently on 0.5mg and have questions about whether the titration is going as expected (or you're considering starting Wegovy and want to understand what the early stages involve) our prescribers are the right people to ask. A free consultation with a real clinician, reviewed the same day, is the practical starting point. That's what the way we work looks like in practice.